SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Overcoming the legal and regulatory barriers to drug repurposing
0 references·7 citing·16 second hop
Overcoming the legal and regulatory barriers to drug repurposing (2018)Overcoming the legal and regulatory barri…European patent protection for medical uses of known products and drug repurposing (2022)European patent protection fo…Drug repositioning: A bibliometric analysis (2022)Drug repositioning: A bibliom…Analysing supply chain coordination mechanisms dealing with repurposing challenges during Covid-19 pandemic in an emerging economy: a multi-layer decision making approach (2022)Analysing supply chain coordi…Mapping the European patent landscape for medical uses of known products (2021)Mapping the European patent l…Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers (2021)Drug repurposing: Misconcepti…On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients (2020)On-Label or Off-Label? Overco…Drug repurposing in rare diseases: Myths and reality (2020)Drug repurposing in rare dise…Challenges and opportunities of drug repositioning (2013)Drug repurposing in oncology—patient and health systems opportunities (2015)Giving Drugs a Second Chance: Overcoming Regulatory and Financial Hurdles in Repurposing Approved Drugs As Cancer Therapeutics (2017)Against pandemic research exceptionalism (2020)Patent landscaping for life sciences innovation: toward consistent and transparent practices (2013)After Myriad, what makes a gene patent claim 'markedly different' from nature? (2017)The Reporting Items for Patent Landscapes statement (2018)Private value of European patents (2007)The Roles Of Academia, Rare Diseases, And Repurposing In The Development Of The Most Transformative Drugs (2015)Intuitionistic fuzzy sets (1986)Supply Chain Coordination with Contracts (2003)Supply chain collaboration: Impact on collaborative advantage and firm performance (2010)Mitigating the damage of a global pandemic on the international buyer-supplier relationship: Evidence from Chinese suppliers (2023)An index to quantify an individual's scientific research output (2005)The History and Meaning of the Journal Impact Factor (2006)The Dynamic Capability View in Strategic Management: A Bibliometric Review (2012)
this work references cited by second hop

References

No references inside the corpus for this window.

Cited by

  • 2021Drug repurposing: Misconceptions, challenges, and opportunities for academic researchers156 cited
  • 2020On-Label or Off-Label? Overcoming Regulatory and Financial Barriers to Bring Repurposed Medicines to Cancer Patients79 cited
  • 2020Drug repurposing in rare diseases: Myths and reality73 cited
  • 2022Drug repositioning: A bibliometric analysis35 cited
  • 2022Analysing supply chain coordination mechanisms dealing with repurposing challenges during Covid-19 pandemic in an emerging economy: a multi-layer decision making approach25 cited
  • 2022European patent protection for medical uses of known products and drug repurposing17 cited
  • 2021Mapping the European patent landscape for medical uses of known products12 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work